HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.
Journal Article
HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.
Full Text
Duke Authors
Cited Authors
- Khurana, S; Norris, PJ; Busch, MP; Haynes, BF; Park, S; Sasono, P; Mlisana, K; Salim, AK; Hecht, FM; Mulenga, J; Chomba, E; Hunter, E; Allen, S; Nemo, G; Rodriguez-Chavez, IR; Women's Interagency HIV Study Collaborative Study Group, ; Margolick, JB; Multicenter AIDS Cohort Study (MACS), ; Golding, H
Published Date
- January 2010
Published In
Volume / Issue
- 48 / 1
Start / End Page
- 281 - 285
PubMed ID
- 19906903
Pubmed Central ID
- 19906903
Electronic International Standard Serial Number (EISSN)
- 1098-660X
Digital Object Identifier (DOI)
- 10.1128/JCM.01573-09
Language
- eng
Conference Location
- United States